Qianru Li

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review.

Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review.

Journal: Pharmaceutics

Published: April 27, 2026

Construction of ROS-Responsive Poly(β-amino ester)-poly(β-thioether ester) Copolymer for Enhancing Gene Delivery and Gene Therapy.

Construction of ROS-Responsive Poly(β-amino ester)-poly(β-thioether ester) Copolymer for Enhancing Gene Delivery and Gene Therapy.

Journal: Biomacromolecules

Published: September 04, 2025

Reshaping tumor immune microenvironment through ROS-responsive prodrug polyplexes via synergistic effect of CRISPRi system and epigenetic inhibitor for breast cancer therapy.

Reshaping tumor immune microenvironment through ROS-responsive prodrug polyplexes via synergistic effect of CRISPRi system and epigenetic inhibitor for breast cancer therapy.

Journal: Materials today. Bio

Published: June 24, 2025

Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma.

Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma.

Journal: Acta biomaterialia

Published: January 28, 2025

Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma.

Integrating bioinformatics and machine learning to identify AhR-related gene signatures for prognosis and tumor microenvironment modulation in melanoma.

Journal: Frontiers in immunology

Published: October 29, 2024

Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety.

Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety.

Journal: Journal of advanced research

Published: January 26, 2024

Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy.

Modified hollow mesoporous silica nanoparticles as immune adjuvant-nanocarriers for photodynamically enhanced cancer immunotherapy.

Journal: Frontiers in bioengineering and biotechnology

Published: September 07, 2022

Photosensitizer-loaded gold nanocages for immunogenic phototherapy of aggressive melanoma.

Photosensitizer-loaded gold nanocages for immunogenic phototherapy of aggressive melanoma.

Journal: Acta biomaterialia

Published: September 17, 2021

Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.

Management of immune checkpoint therapy for patients with cancer in the face of COVID-19.

Journal: Journal for immunotherapy of cancer

Published: October 27, 2020

Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn's Disease.

Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn's Disease.

Journal: Journal of immunology research

Published: April 20, 2020

Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.

Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.

Journal: Cancer medicine

Published: January 13, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026